Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Identification of a m6A RNA methylation regulators-based signature for predicting the prognosis of clear cell renal carcinoma

7 May 2020

Abstract excerpt

Abstract Background The mortality rate of clear cell renal cell carcinoma (ccRCC) remains high. The aim of this study was to identify novel prognostic biomarkers by using m6A RNA methylation regulators capable of improving the risk-stratification criteria of survival for ccRCC patients. Methods The gene expression data of 16 m6A methylation regulators and its relevant clinical information were extracted from The...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Epigenetics and DNA Methylation
Share to Ferroptosis and cancer prognosis
Share to RNA modifications and cancer

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 32419773
DOI: 10.1186/s12935-020-01238-3

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Identification of a m6A RNA methylation regulators-based signature for predicting the prognosis of clear cell renal carcinomaPMID 32419773Read ↗

Construction and validation of an m6A RNA methylation regulator prognostic model for early-stage clear cell renal cell carcinomaSemantic proximity Read ↗

Prognostic Value of an m5C RNA Methylation Regulator-Related Signature for Clear Cell Renal Cell CarcinomaSemantic proximity Read ↗

N6-methyladenosine-related lncRNAs as a biomarker for predicting the prognosis and immune microenvironment of clear cell renal cell carcinomaSemantic proximity Read ↗

Comprehensive Analysis of m5C RNA Methylation Regulator Genes in Clear Cell Renal Cell CarcinomaSemantic proximity Read ↗

The effect of m6A RNA methylation regulators on tumor microenvironment in clear cell renal cell carcinomaSemantic proximity Read ↗

N6-methyladenosine Methylation Related Immune Biomarkers Correlates With Clinicopathological Characteristics and Prognosis in Clear Cell Renal Cell CarcinomaSemantic proximity Read ↗

Integrated analysis on the N6‐methyladenosine‐related long noncoding RNAs prognostic signature, immune checkpoints, and immune cell infiltration in clear cell renal cell carcinomaSemantic proximity Read ↗

Identification of an m6A-Related lncRNA Signature for Predicting the Prognosis in Patients With Kidney Renal Clear Cell CarcinomaSemantic proximity Read ↗

Identification and Comprehensive Validation of a DNA Methylation-Driven Gene-Based Prognostic Model for Clear Cell Renal Cell CarcinomaSemantic proximity Read ↗

Identification and validation of a DNA methylation-driven gene-based prognostic model for clear cell renal cell carcinomaSemantic proximity Read ↗

DNA methylation expression patterns predict outcome of clear cell renal cell carcinomaSemantic proximity Read ↗

A large‐scale transcriptome analysis identified ELANE and PRTN3 as novel methylation prognostic signatures for clear cell renal cell carcinomaSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.